Klasifikasi Kegagalan Pengobatan Penyakit Tuberkulosis (TB) di Kota Mataram Menggunakan Metode Multivariate Adaptive Regression Splines (MARS)
DOI:
10.29303/jm.v8i2.11798Published:
2026-06-13Downloads
Abstract
Tuberculosis (TB) is an infectious disease that affects the lungs and can spread through the air. Indonesia ranks second globally, contributing approximately 10% of the total TB cases worldwide. The Province of Nusa Tenggara Barat (NTB) has been recorded as having a high number of TB cases, with the City of Mataram being one of the areas with the highest incidence. Although TB can be cured through anti-tuberculosis drug (OAT) treatment for six months, the success rate of this treatment has declined since 2016. Several factors such as age, gender, education level, and other health conditions may influence treatment success. Therefore, evaluating treatment outcomes is very important, including monitoring the results of treatment to determine whether the treatment is successful or unsuccessful. In order to classify TB treatment failure, an effective statistical method that can be used is Multivariate Adaptive Regression Splines (MARS). MARS is a flexible nonparametric regression method capable of handling high-dimensional data, making it very useful for classifying data with many predictor variables. This study aims to classify TB treatment failure in the City of Mataram using the MARS method, with the expectation of improving treatment success in the region. Based on the analysis using the MARS method, the type of TB (X₅) was found to be the main determining variable of treatment outcomes, with a fairly good overall classification accuracy of 80%.
Keywords:
classification MARS treatment tuberculosisReferences
Abidin, A. A., Goejantoro, R., & Fathurahman, M. (2023). Klasifikasi penyakit tuberkulosis menggunakan metode Naive Bayes (Studi kasus: Data pasien di Puskesmas Petung Kabupaten Penajam Paser Utara). Eksponensial, 14(1), 11. https://doi.org/10.30872/eksponensial.v14i1.1031
Ananda, R. F., Harsyiah, L., & Alfian, M. R. (2023). Classification of perceptions of the COVID-19 vaccine using multivariate adaptive regression spline. Jurnal Varian, 6(2), 137–148. https://doi.org/10.30812/varian.v6i2.2639
Angka cakupan penemuan dan pengobatan kasus tuberkulosis (treatment coverage TBC) di Nusa Tenggara Barat. (n.d.). Satu Data NTB. https://share.google/MLrhO4lpiSOHGiogb
Arizal, M., Fitriyani, N., & Syechah, B. N. (2024). Modeling factors affecting poverty in Nusa Tenggara using the multivariate adaptive regression spline (MARS) method. MIMS, 24(2), 161–173.
Parida, W. (2023). Penerapan metode multivariate adaptive regression splines dalam pendugaan lama studi mahasiswa matematika FMIPA Universitas Mataram (Skripsi). Universitas Mataram.
Pramesty, A., & Nofrika, V. (2024). Pengetahuan masyarakat tentang penyakit TBC di RW 001 Pulogebang Jakarta Timur periode Maret–April 2024. [Nama Jurnal Tidak Tersedia], 2(2), 31–38.
Rofiq, A., Wuryandari, T., & Rahmawati, R. (2016). Perbandingan analisis diskriminan Fisher dan Naïve Bayes untuk klasifikasi risiko kredit (Studi kasus debitur di Koperasi Jateng Amanah Mandiri Cabang Sukorejo Kendal). Jurnal Gaussian, 5(1), 1–10.
Sihombing, E. D., Sriliana, I., Rini, D. S., & Statistika, P. S. (2024). Klasifikasi status rumah tangga di Provinsi Bengkulu menggunakan multivariate adaptive regression spline (MARS). Jurnal Gaussian, 13(1), 145–155. https://doi.org/10.14710/j.gauss.13.1.145-155
Wulandari, E., & Ronoatmodjo, S. (n.d.). Determinan kegagalan pengobatan pada pasien TBC. https://doi.org/10.7454/epidkes.v8i1.1100
Yasmirullah, S. D. P., Otok, B. W., Purnomo, J. D. T., & Prastyo, D. D. (2021). Parameter estimation of multivariate adaptive regression spline (MARS) with stepwise approach to multi drug-resistant tuberculosis (MDR-TB) modeling in Lamongan Regency. Journal of Physics: Conference Series, 1752(1), 012017. https://doi.org/10.1088/1742-6596/1752/1/012017
License
Copyright (c) 2026 Lisa Harsyiah, Zulhan Widya Baskara, Jihadil Qudsi, Helmina Andriani, Dina Eka Putri

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




